SUVEN

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹378.4

-0.94% today · 30d +20.51%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for SUVEN. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹4 Cr

+91.02% YoY

NET PROFIT

₹-128 Cr

OPM

-1127.01%

+906.17pp YoY

EPS

₹-4.84

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-3.1% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

SUVEN—-77.0

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 100

Valuation — —

Growth STEADY 60

Profitability LOW 5

Technicals STRONG 80

Risk LOW 70

Key Stats

P/B

16.82

52W HIGH

₹403.35

OFF HIGH

-6.19%

MKT CAP

₹10028 Cr

◉ Active Signals

MACDBullish0.9134

RSI(14)Neutral59.5

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SUVEN and at what entry.